• A patient with malignant carcinoid syndrome was treated with a long-acting somatostatin analogue. The cutaneous and systemic improvement our patient had while receiving this therapy is described.
(Arch Dermatol 1989;125:394-396)
Altman AR, Tschen JA, Rice L. Treatment of Malignant Carcinoid Syndrome With a Long-Acting Somatostatin Analogue. Arch Dermatol. 1989;125(3):394–396. doi:10.1001/archderm.1989.01670150084014
Customize your JAMA Network experience by selecting one or more topics from the list below.